The nonspecific inflammatory bowel diseases (IBD) represent a heterogeneous group of
chronic inflammatory disorders of the gastrointestinal tract, and Leśniowski‐Crohn's disease …

Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

Inflammatory bowel disease (IBD), which includes ulcerative colitis, Crohn's disease, and
indeterminate colitis, is characterized by chronic inflammation of the digestive tract and has …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial
recognition of an inflammatory condition, followed by definitive endoscopic, histological and …

Inflammatory bowel diseases (IBD) comprise two major forms: Crohn's disease and
ulcerative colitis. The diagnosis of IBD is based on clinical symptoms combined with results …

The traditional diagnosis of inflammatory bowel disease (IBD) relies on a combination of
endoscopic, radiologic, clinical, laboratory, and pathologic studies. Typical laboratory …

Introduction: Traditional diagnosis and classification of inflammatory bowel diseases (IBDs)
have been based on clinical evaluation, laboratory testing, endoscopy, imaging, and …

There is no gold standard for the diagnosis and monitoring of inflammatory bowel diseases
(IBD). Biomarkers are useful tools for the management of patients suffering from IBD …

In recent years the use of faecal and serologic biomarkers has been evaluated in the
diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) …